Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,350 stories, page 383 of 673

Advanced search

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07673900: Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07669077: A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07650799: AI-assisted Rare Disease Diagnosis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07581002: A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07559136: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07512128: Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE [Investigational Device Exemption] Study)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07421570: The Effect of Capacitive and Resistive Electrical Transfer Therapy on Hamstring Injuries

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07394049: A Prospective Multicenter Cohort Study of Contemporary Menopausal Hormone Therapy and Cardiovascular Outcomes

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07281430: Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07227532: A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07106632: Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07062471: Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT07006636: Effect of Watermelon on Cardiometabolic Health

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06954337: MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06816511: Preliminary Explorative Study of Magnetic Resonance-Guided Focused Ultrasound Surgery in Refractory Obsessive-Compulsive Disorder Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06690398: Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06637332: Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06458998: Getting To Implementation: Improving Cancer Screening for Veterans

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06139016: Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT06100744: A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT05600894: Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT05488314: A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT05045820: Integrative Medicine in Pain Management in Sickle Cell Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT04847453: Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT04708431: Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT04671667: Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT04616560: Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03914300: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03842228: Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03839212: The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03775265: Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03767244: A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03712605: Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03528642: Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT03394365: A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT02314169: Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT02196181: Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT01142388: Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT00977574: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 31Researchclinicaltrials.govTier 1 · Trial registry

NCT00114101: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Is Reta Safe?

Yahoo CreatorsOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

IKS04 Utilizing Ligachem Bio Platform Receives FDA Clinical Trial Approval

아시아경제Original source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Compounding must not become a drug-approval shortcut for Big Wellness

Washington TimesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Aardvark Therapeutics (AARD) Scrutinized Again After FDA Hold on Lead Drug Candidate, May Announcement Drives Stock 32% Lower - Hagens Berman

MorningstarOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class H – HKEX:1349

TradingViewOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

CHA Biotech Co., Ltd. Revenue Breakdown – KRX:085660

TradingViewOriginal source

🌍Jul 31discoverynews.google.comTier 1 · Regulatory source

Outbreak Investigation of E. coli: Frozen Blueberries (July 2026)

fda.govOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Investors Purchase High Volume of Put Options on Teva Pharmaceutical Industries (NYSE:TEVA)

MarketBeatOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Early surgery for bacterial eye infection offers hope to patients

Medical XpressOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Pharma Fundamentals: Hold Times in Biopharmaceuticals, an Introduction

PharmTech.comOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Federal biotech commission examines Colorado’s role in critical minerals production

Denver GazetteOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients

Investing News NetworkOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Targets High Drug Prices, Seeks NPPA Action

WhalesbookOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Regulation and policy update for H2 2026

BioTechniquesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

FDA Panel Backs Peptide BPC-157 for Compounding in 8-6 Vote Over Scientists' Objections

Tech TimesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Apple Tree Gets $4M For Biotech Cos. As Managers Take Over

Law360Original source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

NeuroSense Therapeutics (NRSN) sets $150M shelf and $3.8M ATM share plan

stocktitan.netOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA trains guns on overpriced drugs

The Economic TimesOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer

KaryopharmOriginal source

🌍Jul 31discoverynews.google.comTier 3 · Aggregated media

Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway

TradingViewOriginal source